International Ataxia Rating Scale in Younger Patients

Key facts

Sponsor

Quince Therapeutics S.p.A.

Principal Investigator

Luca Benatti, MD

Quince Therapeutics S.p.A.

Enrollment

63 enrolled

Eligibility

6-18 years · All sexes

Timeline

2013 – 2014

Study locations (5)

• Carol Morsani USF Health Center, Tampa, Florida, United States
• Jaslok Hospital, Mumbai, India
• Edmond and Lilly Safra Childrens Hospital Pediatric Unit, Tel Litwinsky, Israel
• Università La Sapienza, Roma, Italy, Italy
• A.O Spedalli Civilli Brescia, Brescia, Italy

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Ataxia-telangiectasia

Additional recruiting or active studies for the same condition.

• ACTIVE NOT RECRUITINGPHASE3NCT06673056
  A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)
  IntraBio Inc
• ACTIVE NOT RECRUITINGPHASE2NCT04870866
  NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia
  University Hospital, Akershus

See all trials for Ataxia-telangiectasia →